Patent Assignment
Reel/Frame 069476/0380
Patent Security Agreement
Recorded: 2024-12-03
Pages: 10
Assignor
SOLARIS IPCO LIMITED
Executed: 2024-11-29
Assignee
NOMURA CORPORATION FUNDING AMERICAS, LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
309 WEST 49TH STREET, NEW YORK, NEW YORK, 10019
Covered Properties
(27)
Method and Apparatus for the Continuous Separation of Biological Fluids into Components
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Method and Apparatus for Collecting a Blood Component and Performing a Photopheresis Treatment
Phototherapy Compositions and Methods
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Phototherapy Compositions and Methods
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Centrifuge System and Method with Component Tracking
Patent:
10,434,239 →
Application:
15/261,968 →
Support for Centrifuge Tubing
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Processing Blood
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Processing Blood
Processing Blood
Centrifuge System and Method with Component Tracking
Patent:
11,020,522 →
Application:
16/537,103 →
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Processing Blood
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Application:
17/458,206 →
Publication:
US 2021/0388318
Method for Generating Immunoregulatory Cells in a Blood-Derived Sample
Method of Extracorporeal Photopheresis for Immune-Related Adverse Events
Application:
18/103,202 →
Publication:
US 2023/0165961
Adiponectin Alone or in Combination with Extracorporeal Photopheresis (Ecp) for Immune Related Adverse Events of Immune Checkpoint Inhibitors
Application:
18/392,250 →
Publication:
US 2024/0307497
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Application:
18/640,626 →
Publication:
US 2024/0261488
Adiponectin Alone or in Combination with Extracorporeal Photopheresis (Ecp) for Immune Related Adverse Events of Immune Checkpoint Inhibitors
Application:
63/517,685 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 6, 2018
From: BRIGGS, DENNIS; DO, SIMON; VANDLIK, MARK; MURPHY, KEVIN
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 046280/0436 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 049643/0168 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049643/0282 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 049643/0348 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049643/0397 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 050056/0219 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 050056/0303 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 050056/0122 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 050056/0042 →
Nunc Pro Tunc Assignment
Aug 15, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 050061/0605 →
Nunc Pro Tunc Assignment
Aug 15, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 050061/0438 →
Nunc Pro Tunc Assignment
Aug 15, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 050061/0498 →
Nunc Pro Tunc Assignment
Aug 15, 2019
From: THERAKOS, INC
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 050061/0371 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Assignment of Assignor's Interest
Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 056433/0640 →
Change of Name
Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 056476/0162 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 036662, Frame 0053
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0503 →
Release of Patent Security Interests Recorded at Reel 049822, Frame 0674
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0454 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →